Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.1769
+0.0060 (3.51%)
At close: May 16, 2025, 4:00 PM
0.1688
-0.0081 (-4.58%)
After-hours: May 16, 2025, 7:59 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $22.09 million as of May 16, 2025. Its market cap has decreased by -81.71% in one year.
Market Cap
22.09M
Enterprise Value
-7.48M
1-Year Change
-81.71%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $22.09M, a decrease of -98.30%. That is a compound annual growth rate of -61.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 22.09M | -84.02% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 661.72B |
| Johnson & Johnson | 358.60B |
| AbbVie | 318.45B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 247.12B |
| Abbott Laboratories | 231.49B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |